|
|
||||||||||||||
|
|
|||||||||||||||
a Centre for Research
in Women's Health, University of Toronto, 790 Bay Street, Suite 750A,
Toronto, Ontario M5G 1N8, Canada, b Division of
Medical Genetics, Department of Medicine, McGill University, Montreal,
Quebec H3G 1A4, Canada
Correspondence to: Dr Narod, narod{at}itn.net
Revised version received 26 May 2000;
Accepted for publication 5 June
2000
BACKGROUND
The discovery of the
breast and ovarian cancer susceptibility genes
BRCA1 and BRCA2
has improved our ability to counsel women at increased risk of
developing breast and ovarian cancer. The objective of our study was to
identify the needs of women who have undergone genetic counselling and
testing for
BRCA1/2 and to
determine the impact of receiving a positive
BRCA1/2 result. This is the first study to report on a large group of women who have
received positive
BRCA1/2 mutation results.
METHODS
Questionnaires were
distributed to 105 women who had received pre- and post-test genetic
counselling for a positive
BRCA1/2 result at
the University of Toronto or at McGill University in Montreal, Canada
between the years of 1994 and 1998. The questionnaire items included
patient motivation for seeking genetic services, information needs,
screening and prophylactic surgery practices, satisfaction with access
to services and support, the desire for a support group, and overall
client satisfaction.
RESULTS
Seventy nine female
carriers were surveyed. The majority of the respondents (77%) were
satisfied with the information they received during the genetic
counselling process. Women with a previous diagnosis of cancer
indicated that they needed more information relating to cancer
treatment compared to women without cancer (p=0.05). Nineteen percent
of the women felt they needed more support than was received. Fifty
eight percent of the women reported that their screening practices had
changed since they received their result. Young women (below the age of
50) and women with no previous diagnosis of cancer were most likely to
have changed their screening practices. Nearly two thirds of the
respondents said they had considered prophylactic surgery of the
breasts or ovaries. Twenty eight percent of the women had prophylactic
mastectomy and 54% had undergone prophylactic oophorectomy. Women with
an educational level of high school or more were more likely to have undergone prophylactic bilateral mastectomy than those with less education (p=0.07) but were less likely to undergo prophylactic oophorectomy (p=0.0007).
CONCLUSION
These findings
have a direct impact on the counselling and risk management of
female BRCA mutation carriers. Age,
education, and a previous diagnosis of cancer are important
determinants in a woman's decision making after receiving positive
genetic test results.
This article has been cited by other articles:
![]() |
C. H. Halbert, L. Wenzel, C. Lerman, B. N. Peshkin, S. Narod, A. Marcus, C. Corio, T. Demarco, and S. Bellamy Predictors of Participation in Psychosocial Telephone Counseling following Genetic Testing for BRCA1 and BRCA2 Mutations Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 875 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cullen, M. D. Schwartz, W. F. Lawrence, J. V. Selby, and J. S. Mandelblatt Short-Term Impact of Cancer Prevention and Screening Activities on Quality of Life J. Clin. Oncol., March 1, 2004; 22(5): 943 - 952. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Braithwaite, J. Emery, F. Walter, A. T. Prevost, and S. Sutton Psychological Impact of Genetic Counseling for Familial Cancer: A Systematic Review and Meta-analysis J Natl Cancer Inst, January 21, 2004; 96(2): 122 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
C J van Asperen, S van Dijk, M W Zoeteweij, D R M Timmermans, G H de Bock, E J Meijers-Heijboer, M F Niermeijer, M H Breuning, J Kievit, and W Otten What do women really want to know? Motives for attending familial breast cancer clinics J. Med. Genet., June 1, 2002; 39(6): 410 - 414. [Full Text] [PDF] |
||||
![]() |
Y. Wang, J. Tan, M. Sutton-Smith, D. Ditto, M. Panico, R. M. Campbell, N. M. Varki, J. M. Long, J. Jaeken, S. R. Levinson, et al. Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis Glycobiology, December 1, 2001; 11(12): 1051 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Prospero, M. Seminsky, J. Honeyford, B. Doan, E. Franssen, W. Meschino, P. Chart, E. Warner, and M. J. Esplen Support groups for people carrying a BRCA mutation Can. Med. Assoc. J., September 1, 2001; 165(6): 740 - 742. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |